Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
Andrew J. Perrin, Mark Horowitz, Jacob Roelofs, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Social Determinants of Cardiovascular Disease
Tiffany M. Powell‐Wiley, Yvonne Baumer, Foster Osei Baah, et al.
Circulation Research (2022) Vol. 130, Iss. 5, pp. 782-799
Open Access | Times Cited: 476
Molecular pathways of major depressive disorder converge on the synapse
Gabriel R. Fries, Valeria Saldana, Johannes Finnstein, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 284-297
Open Access | Times Cited: 249
The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?
Błażej Misiak, Igor Łoniewski, Wojciech Marlicz, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 102, pp. 109951-109951
Open Access | Times Cited: 248
Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 210
Childhood trauma, HPA axis activity and antidepressant response in patients with depression
Naghmeh Nikkheslat, Anna McLaughlin, Caitlin Hastings, et al.
Brain Behavior and Immunity (2019) Vol. 87, pp. 229-237
Open Access | Times Cited: 103
Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study
Annamaria Cattaneo, Clarissa Ferrari, Lorinda Turner, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 91
Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
Katrien Skorobogatov, Livia De Picker, Robert Verkerk, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 66
The immunology of stress and the impact of inflammation on the brain and behaviour
Meghna Ravi, Andrew H. Miller, Vasiliki Michopoulos
BJPsych Advances (2021) Vol. 27, Iss. 3, pp. 158-165
Open Access | Times Cited: 60
The interplay of hypoxic and mental stress: Implications for anxiety and depressive disorders
Johannes Burtscher, Martin Niedermeier, Katharina Hüfner, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 138, pp. 104718-104718
Open Access | Times Cited: 53
Enhanced antidepressant effects of BDNF-quercetin alginate nanogels for depression therapy
Dong Xu, Li-Na Gao, Xujiao Song, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 27
By what molecular mechanisms do social determinants impact cardiometabolic risk?
Yvonne Baumer, Mario A. Pita, Andrew S. Baez, et al.
Clinical Science (2023) Vol. 137, Iss. 6, pp. 469-494
Open Access | Times Cited: 26
Psychoneuroendocrinology
Luca Sforzini, Frances Isabella Weston, Carmine M. Pariante
American Psychiatric Association Publishing eBooks (2024)
Closed Access | Times Cited: 11
How inflammation influences psychiatric disease
Eduardo Ferat‐Osorio, José Luis Maldonado-García, Lenin Pavón
World Journal of Psychiatry (2024) Vol. 14, Iss. 3, pp. 342-349
Open Access | Times Cited: 9
Brain-immune crosstalk in the treatment of major depressive disorder
Igor Branchi, S. Poggini, Lucile Capuron, et al.
European Neuropsychopharmacology (2020) Vol. 45, pp. 89-107
Open Access | Times Cited: 56
Neuroimmunology of depression
Erika Sarno, Adam J. Moeser, Alfred J. Robison
Advances in pharmacology (2021), pp. 259-292
Open Access | Times Cited: 54
Biomarkers common for inflammatory periodontal disease and depression: A systematic review
Sudan Prasad Neupane, Anca Virtej, Lene Myhren, et al.
Brain Behavior & Immunity - Health (2022) Vol. 21, pp. 100450-100450
Open Access | Times Cited: 36
Cause or consequence? Understanding the role of cortisol in the increased inflammation observed in depression
Nare Amasi-Hartoonian, Luca Sforzini, Annamaria Cattaneo, et al.
Current Opinion in Endocrine and Metabolic Research (2022) Vol. 24, pp. 100356-100356
Open Access | Times Cited: 32
Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation
Alexander Refisch, Zümrüt Duygu Şen, Tilman E. Klassert, et al.
Neuropharmacology (2023) Vol. 235, pp. 109568-109568
Open Access | Times Cited: 18
The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis
Mia R Burke, Ioannis Sotiropoulos, Clarissa L. Waites
Trends in Neurosciences (2024) Vol. 47, Iss. 11, pp. 933-948
Closed Access | Times Cited: 8
Glucocorticoids prime the inflammatory response of human hippocampal cells through up-regulation of inflammatory pathways
Mark Horowitz, Annamaria Cattaneo, Nadia Cattane, et al.
Brain Behavior and Immunity (2020) Vol. 87, pp. 777-794
Open Access | Times Cited: 42
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder
Francesco Benedetti, Sara Poletti, Benedetta Vai, et al.
European Neuropsychopharmacology (2020) Vol. 42, pp. 35-44
Closed Access | Times Cited: 40
Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments
Brandon Richardson, Andrew J. Macpherson, Francis Rodriguez Bambico
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100554-100554
Open Access | Times Cited: 28
The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms
Vincenzo Dattilo, Rosario Amato, Nicola Perrotti, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 36
The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression
Leszek Rudzki, Michaël Maes
Molecular Neurobiology (2020) Vol. 57, Iss. 10, pp. 4269-4295
Closed Access | Times Cited: 36
Low glucocorticoids in stress-related disorders: the role of inflammation
Alexey Sarapultsev, Petr Sarapultsev, Eliyahu Dremencov, et al.
Stress (2020) Vol. 23, Iss. 6, pp. 651-661
Closed Access | Times Cited: 35
Page 1 - Next Page

Scroll to top